| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 360 | $70 | $24.5K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 180 | $120 | $22.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 220 | $50 | $11.8K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 80 | $70 | $5.5K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 20 | $270 | $5.1K |
| 77067 | The provider takes two X–ray views of each breast for routine screening and may use specially designed computer software to help identify any potential abnormalities within the images; the software… | 50 | $90 | $4.1K |
| 99495 | The provider manages the care of a patient during the transition to home care after discharge from a healthcare facility. The patient’s care requires at least moderate medical decision making,… | 20 | $140 | $3.3K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 20 | $130 | $2.7K |
| Q3014 | Telehealth originating site facility fee | 110 | $20 | $2.5K |
| G0008 | Administration of influenza virus vaccine | 90 | $30 | $2.5K |